 |
인쇄하기
취소
|
Prices of statin based hyperlipemic medicines to be reduced
The Health Review Insurance Agency says health insurance prices of statin based hyperlipemic agents, such as Pfizer’s Lipitor, will be reduced as a result of evaluating the economic effectiveness of those medicines, except for simvastatin preparation.
For the reassessment and cutbacks of the drug prices the agency has applied weighted averaged prices of drugs over the price of simvastatin.
...
For the reassessment and cutbacks of the drug prices the agency has applied weighted averaged prices of drugs over the price of simvastatin.
...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.